Home

About Us

Pharma-Free CME

Resources by Topic

Resources by Type

Teaching Tools

Drug Industry

Contact Us

How You Can Help

RSS NEWS FEED

About Us

PharmedOut is an independent project run by physicians for physicians and other prescribers. Our goals are to:

Document and disseminate information about how pharmaceutical companies influence prescribing

Provide access to unbiased information about drugs

Encourage physicians to choose pharma-free CME

PharmedOut is led by a team of physicians and academics and is contributed to by a diverse group. The Principal Investigator is Adriane Fugh-Berman MD and the Project Manager is Alicia M. Bell MS. Contact PharmedOut

What We Do

We provide lectures at Grand Rounds, meetings, conferences, and medical student events.
Invite PharmedOut to speak (Lecture Topics)

We provide access to free, web-based, pharma-free CME – enough for any physician in the U.S to fulfill annual CME requirements without taking industry-funded courses.

PharmedOut CME Modules:

Drug Approval in the U.S. (1.0 CME credit)

Generic Drugs: Prescribing Sensibly (1.0 CME credit)

Links to more than 200 more credits of web-based, free, pharma-free CME

We provide news, information, and resources, including our own slideshows, videos, and other audio-visual material, reading recommendations, resources for unbiased drug information, factsheets, and tools for teaching--including the popular Drug Ad Bingo.

PharmedOut slideshows are open access and available for anyone to see, download, or use (we only ask that you credit us.) How to use our materials

Patient factsheets are available: Fast Facts on Generic Drugs

Our PharmedOut videos provide illuminating glimpses behind the scenes through interviews with former and current industry insiders. Transcripts are available too.

Our news section provides a mix of mainstream and not-so-mainstream news. Subscribe to our RSS feed. Read our PharmedOut publications and media mentions.

How You Can Help

PharmedOut is funded through the Attorney General Consumer and Prescriber Education grant program, created as part of a 2004 settlement between Warner-Lambert, a division of Pfizer, Inc., and the Attorneys General of 50 States and the District of Columbia, to settle allegations that Warner-Lambert conducted an unlawful marketing campaign for the drug Neurontin® (gabapentin) that violated state consumer protection laws.

---

Who We Are

Adriane Fugh-Berman, MD

Principal Investigator
Contact Dr. Fugh-Berman


Alicia M. Bell, MS

Project Manager
Contact Ms. Bell

---

Our Videos



Pharma Insider II
Opposition research
(read transcript)

---

Pharma Insider I
Off-label promotion under the radar
(read transcript)

---

The Art of Medical Writing
Pharma's anonymous writers

---

Drug Reps Talk Shop II
Drug reps continue their chat

---

Drug Reps Talk Shop I Selling drugs to docs

---

Director of PharmedOut Explains the Project

---

Zyprexa Drug Rep Tells All Shahram Ahari describes how he sold the drug

---

News

Analysis Finds Vioxx's Heart Attack Risk in 2001
35% increase in CV events WSJ

---

States, Consumer Advocates Challenge Rx Data Mining
FDA has been silent Chicago Tribune

---

Researcher Seeks New Treatments in Old Drugs
Bioinformatics promising Houston Chronicle

---

Some Doctors Say No More Free Lunches
“Goodies” are a conflict of interest Rapid City Journal

---

Study Raises Questions About Cholesterol Drug’s Benefit
Niacin bests Zetia NYT

---

Drug Makers Raise Prices in Face of Health Care Reform
Wholesale prices up 9% NYT

---

Unpublished Clinical Trials with Sumatriptan
Drug less effective Lancet (read commentary)

---

In House, Many Spoke With One Voice: Lobbyists’
Ghostwritten remarks underwritten by Genentech NYT

---

Health-Bill Disclosure Rule Is Resisted
CME funding at issue WSJ

---

Generic-Drug Makers Protest Supply Limits
FTC examines pharma practices
WSJ

---

At Top Schools, More Than Half the Profs Have Industry Ties
50 NIH-funded institutions surveyed WSJ Health Blog (read study and comments)

---

Commentary

Mammography and the Corporate Breast
Conflicts of USPSTF critics not mentioned Bioethics Forum

---

Click HERE to read the entire news archives